Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma.

about

Arctigenin Inhibits Liver Cancer Tumorigenesis by Inhibiting Gankyrin Expression via C/EBPα and PPARα.

P2860

Q52595227-CCC48F1C-BB6D-43D9-9AF6-DE240DD1339B

P2860

Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q42288668

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Gankyrin induces STAT3 activat ...... e in hepatocellular carcinoma.

@en

Gankyrin induces STAT3 activat ...... e in hepatocellular carcinoma.

@nl

type

Item

label

Gankyrin induces STAT3 activat ...... e in hepatocellular carcinoma.

@en

Gankyrin induces STAT3 activat ...... e in hepatocellular carcinoma.

@nl

prefLabel

Gankyrin induces STAT3 activat ...... e in hepatocellular carcinoma.

@en

Gankyrin induces STAT3 activat ...... e in hepatocellular carcinoma.

@nl

P1476

Gankyrin induces STAT3 activat ...... e in hepatocellular carcinoma.

@en

P2093

Ken Kamata

http://www.w3.org/2001/XMLSchema#string

Kosuke Minaga

http://www.w3.org/2001/XMLSchema#string

Mamoru Takenaka

http://www.w3.org/2001/XMLSchema#string

Naoshi Nishida

http://www.w3.org/2001/XMLSchema#string

Norihisa Yada

http://www.w3.org/2001/XMLSchema#string

Satoru Hagiwara

http://www.w3.org/2001/XMLSchema#string

Tadaaki Arizumi

http://www.w3.org/2001/XMLSchema#string

Tomohiro Watanabe

http://www.w3.org/2001/XMLSchema#string

Toshiharu Sakurai

http://www.w3.org/2001/XMLSchema#string

Yasunori Minami

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas

Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties

The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53

Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Gankyrin is an ankyrin-repeat oncoprotein that interacts with CDK4 kinase and the S6 ATPase of the 26 S proteasome

Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production

Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation

Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo

SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinoma

P304

1996-2003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.13341

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Masatoshi Kudo

P577

2017-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28777492

http://www.w3.org/2001/XMLSchema#string

P932

5623735

http://www.w3.org/2001/XMLSchema#string

Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma.

about

P2860

P2860

Gankyrin induces STAT3 activation in tumor microenvironment and sorafenib resistance in hepatocellular carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932